Cyclic HIV-1 protease inhibitors derived from mannitol: Synthesis, inhibitory potencies, and computational predictions of binding affinities

被引:157
作者
Hulten, J
Bonham, NM
Nillroth, U
Hansson, T
Zuccarello, G
Bouzide, A
Aqvist, J
Classon, B
Danielson, UH
Karlen, A
Kvarnstrom, I
Samuelsson, B
Hallberg, A
机构
[1] UNIV UPPSALA, UPPSALA BIOMED CTR, DEPT ORGAN PHARMACEUT CHEM, S-75123 UPPSALA, SWEDEN
[2] UNIV UPPSALA, UPPSALA BIOMED CTR, DEPT BIOCHEM, S-75123 UPPSALA, SWEDEN
[3] UNIV UPPSALA, UPPSALA BIOMED CTR, DEPT MOL BIOL, S-75124 UPPSALA, SWEDEN
[4] LINKOPING UNIV, DEPT CHEM, S-58183 LINKOPING, SWEDEN
[5] MEDIVIR AB, S-14144 HUDDINGE, SWEDEN
[6] UNIV STOCKHOLM, ARRHENIUS LAB, DEPT ORGAN CHEM, S-10691 STOCKHOLM, SWEDEN
关键词
D O I
10.1021/jm960728j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ten C-2-symmetric cyclic urea and sulfamide derivatives have been synthesized from L-mannonic gamma-lactone and D-mannitol. The results of experimental measurement of their inhibitory potencies against HIV-1 protease were compared to calculated free energies of binding derived from molecular dynamics (MD) simulations. The compounds were selected, firstly, to enable elucidation of the role of stereochemistry for binding affinity (1a-d) and, secondly, to allow evaluation of the effects of variation in the link to the P1 and P1' phenyl groups on affinity (la and 2-5). Thirdly, compounds with hydrogen bond-accepting or -donating groups attached to the phenyl groups in the P2 and P2' side chains (6 and 7) were selected. Binding free energies were estimated by a linear response method, whose predictive power for estimating binding affinities from MD simulations was demonstrated.
引用
收藏
页码:885 / 897
页数:13
相关论文
共 79 条
[1]  
AQVIST J, 1995, J BIOL CHEM, V270, P9978
[2]  
Aqvist J, 1996, J COMPUT CHEM, V17, P1587, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1587::AID-JCC1>3.0.CO
[3]  
2-H
[4]   NEW METHOD FOR PREDICTING BINDING-AFFINITY IN COMPUTER-AIDED DRUG DESIGN [J].
AQVIST, J ;
MEDINA, C ;
SAMUELSSON, JE .
PROTEIN ENGINEERING, 1994, 7 (03) :385-391
[5]   On the validity of electrostatic linear response in polar solvents [J].
Aqvist, J ;
Hansson, T .
JOURNAL OF PHYSICAL CHEMISTRY, 1996, 100 (22) :9512-9521
[6]  
AQVIST J, 1993, J AM CHEM SOC, V115, P631
[7]  
ARYA VP, 1976, INDIAN J CHEM B, V14, P766
[8]   OPTIMAL-DESIGN FOR MODEL DISCRIMINATION USING THE F-TEST WITH NON-LINEAR BIOCHEMICAL-MODELS - CRITERIA FOR CHOOSING THE NUMBER AND SPACING OF EXPERIMENTAL POINTS [J].
BARDSLEY, WG ;
MCGINLAY, PB ;
ROIG, MG .
JOURNAL OF THEORETICAL BIOLOGY, 1989, 139 (01) :85-102
[9]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[10]  
Berendsen H. J., 1981, Intermolecular Forces, DOI [10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658-1_21]